Description
N-acetylcysteine (NAC) has been widely used in the treatment of liver failure secondary to acetaminophen overdose. At Valley Hospital Medical Center (VHMC) and other Valley Health System hospitals, NAC has been used as an off-label treatment for non-acetaminophen-induced acute liver failure (NAI-ALF) and ischemic hepatitis. Studies have shown NAC is safe for use in NAI-ALF and may provide a survival benefit in native liver without transplantation. While some evidence suggests potential benefits of NAC for NAI-ALF, lack of robust, high-quality studies limits its widespread adoption and routine use. The objective of this study is to evaluate the effectiveness of NAC in reducing ALT and AST within 72 hours in patients with NAI-ALF.
Disciplines
Health Services Research | Medical Education | Medical Sciences | Medicine and Health Sciences
Keywords
N-acetylcysteine, non-acetaminophen-induced acute liver failure, NAC, NAI-ALF
Recommended Citation
Ramirez, Edward; Whittaker, Alana; and Putney, Kaylee, "Impact of N-acetylcysteine in non-acetaminophen-induced acute liver failure: A retrospective analysis" (2025). Annual Research Symposium. 31.
https://ecommons.roseman.edu/researchsymposium/2025/clinical/31